{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:08:36Z","timestamp":1791328116990,"version":"4.3.1"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,15]]},"DOI":"10.18632\/oncotarget.12766","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:33:46Z","timestamp":1476923626000},"page":"74415-74426","source":"Crossref","is-referenced-by-count":26,"title":["Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing<i>MYCN<\/i>in<i>hGFAP<\/i>-positive cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Kathrin","family":"Fielitz","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Althoff","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katleen","family":"De Preter","sequence":"additional","affiliation":[{"name":"Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Nonnekens","sequence":"additional","affiliation":[{"name":"Genetics and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Ohli","sequence":"additional","affiliation":[{"name":"Center for Neuropathology, Ludwig-Maximilians University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Elges","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Kl\u00f6ppel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Technical University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kn\u00f6sel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ludwig-Maximilians University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schulte","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Klein-Hitpass","sequence":"additional","affiliation":[{"name":"Cell Biology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Beisser","sequence":"additional","affiliation":[{"name":"Genome Informatics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Reis","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Eyking","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Cario","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.","family":"Schulte","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology, Charit\u00e9 University Medicine, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schramm","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sch\u00fcller","sequence":"additional","affiliation":[{"name":"Center for Neuropathology, Ludwig-Maximilians University, Munich, Germany"},{"name":"Institute of Neuropathology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Research Institute Childrens Cancer Center, Hamburg, Germany"},{"name":"Department of Pediatric Oncology and Hematology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","article-title":"c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells","volume":"151","author":"Levens","year":"2012","journal-title":"Cell"},{"key":"2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature13473","article-title":"Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles","volume":"511","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/305245a0","article-title":"Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour","volume":"305","author":"Trent","year":"1983","journal-title":"Nature"},{"key":"4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2014.07.015","article-title":"Drugging MYCN through an allosteric transition in Aurora kinase A","volume":"26","author":"Weiss","year":"2014","journal-title":"Cancer Cell"},{"key":"5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Dyer","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1093\/emboj\/16.11.2985","article-title":"Targeted expression of MYCN causes neuroblastoma in transgenic mice","volume":"16","author":"Bishop","year":"1997","journal-title":"EMBO J"},{"key":"7","article-title":"A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies","author":"Kumps","year":"2014","journal-title":"Oncogene"},{"key":"8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ccr.2012.04.012","article-title":"Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC","volume":"21","author":"Weiss","year":"2012","journal-title":"Cancer Cell"},{"key":"9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1541-7786.MCR-13-0536","article-title":"The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential","volume":"12","author":"Beltran","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00428-014-1657-8","article-title":"Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases","volume":"465","author":"Freier","year":"2014","journal-title":"Virchows Arch"},{"key":"11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12029-011-9258-0","article-title":"Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc","volume":"42","author":"Navarro","year":"2011","journal-title":"J Gastrointest Cancer"},{"issue":"Suppl 1","key":"12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1530\/ERC-11-0013","article-title":"Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms","volume":"18","author":"Kl\u00f6ppel","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"13","first-page":"258","article-title":"Update on pancreatic neuroendocrine tumors","volume":"3","author":"Edil","year":"2014","journal-title":"Gland Surg"},{"key":"14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/en.2014-1433","article-title":"Conditional deletion of Men1 in the pancreatic beta-cell leads to glucagon-expressing tumor development","volume":"156","author":"Ning","year":"2015","journal-title":"Endocrinology"},{"key":"15","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1038\/onc.2013.514","article-title":"Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma","volume":"33","author":"Gross","year":"2014","journal-title":"Oncogene"},{"key":"16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Chicas","year":"2011","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccr.2013.05.005","article-title":"Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma","volume":"24","author":"Chesler","year":"2013","journal-title":"Cancer Cell"},{"key":"18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/2159-8290.CD-12-0418","article-title":"Targeting MYCN in neuroblastoma by BET bromodomain inhibition","volume":"3","author":"Benes","year":"2013","journal-title":"Cancer Discov"},{"key":"19","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s00125-012-2696-9","article-title":"The role of Raf-1 kinase inhibitor protein in the regulation of pancreatic beta cell proliferation in mice","volume":"55","author":"Gasa","year":"2012","journal-title":"Diabetologia"},{"key":"20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/bjc.2015.188","article-title":"Augmented expression of MYC and\/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study","volume":"113","author":"Seeger","year":"2015","journal-title":"Br. J. Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1177\/002215540004800907","article-title":"GFAP is expressed as a major soluble pool associated with glucagon secretory granules in A-cells of mouse pancreas","volume":"48","author":"Bastianini","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/002215540004800211","article-title":"Glial fibrillary acidic protein (GFAP)-like immunoreactivity in rat endocrine pancreas","volume":"48","author":"Bertelli","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional amplification in tumor cells with elevated c-Myc","volume":"151","author":"Young","year":"2012","journal-title":"Cell"},{"key":"24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature13537","article-title":"Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis","volume":"511","author":"Bianchi","year":"2014","journal-title":"Nature"},{"key":"25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc3984","article-title":"MYC: connecting selective transcriptional control to global RNA production","volume":"15","author":"Amati","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"26","first-page":"697","article-title":"Gastrointestinal endocrine tumours","volume":"10","author":"Bloom","year":"1996","journal-title":"Glucagonomas Baillieres Clin Gastroenterol"},{"key":"27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s005340050052","article-title":"Glucagonomas\/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases","volume":"5","author":"Yakuwa","year":"1998","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"28","first-page":"1197","article-title":"Necrolytic migratory erythema with pancreatic carcinoma","volume":"64","author":"Wilkinson","year":"1971","journal-title":"Proc R Soc Med"},{"key":"29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0889-8553(21)00444-1","article-title":"Glucagonomas and insulinomas","volume":"18","author":"Boden","year":"1989","journal-title":"Gastroenterol Clin North Am"},{"key":"30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","article-title":"Multiple endocrine neoplasia type 1 (MEN1)","volume":"24","author":"Thakker","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"31","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1210\/en.2009-1251","article-title":"Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice","volume":"151","author":"Libutti","year":"2010","journal-title":"Endocrinology"},{"key":"32","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1158\/0008-5472.CAN-04-0931","article-title":"Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish","volume":"64","author":"Look","year":"2004","journal-title":"Cancer Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"e23397","DOI":"10.1371\/journal.pone.0023397","article-title":"Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice","volume":"6","author":"Ren","year":"2011","journal-title":"PLoS ONE"},{"key":"34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2008.12.005","article-title":"Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma","volume":"15","author":"Eilers","year":"2009","journal-title":"Cancer Cell"},{"key":"35","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1158\/1078-0432.CCR-15-1449","article-title":"Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition","volume":"22","author":"Heukamp","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.18632\/oncotarget.1534","article-title":"BET bromodomain protein inhibition is a therapeutic option for medulloblastoma","volume":"4","author":"Eggert","year":"2013","journal-title":"Oncotarget"},{"key":"37","doi-asserted-by":"crossref","first-page":"9489","DOI":"10.1038\/srep09489","article-title":"GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1","volume":"5","author":"Munshi","year":"2015","journal-title":"Sci Rep"},{"key":"38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/gene.10008","article-title":"hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo","volume":"31","author":"Messing","year":"2001","journal-title":"Genesis"},{"key":"39","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1053\/j.gastro.2011.08.043","article-title":"Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer","volume":"141","author":"Cario","year":"2011","journal-title":"Gastroenterology"},{"key":"40","doi-asserted-by":"crossref","first-page":"14094","DOI":"10.1073\/pnas.0804455105","article-title":"High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma","volume":"105","author":"P\u00e5hlman","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T19:48:34Z","timestamp":1657482514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,19]]},"references-count":40,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2016,11,15]]}},"alternative-id":["12766","27769070"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12766","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,19]]}}}